Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sham Mailankody

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
The Oncologist|October 10, 2015
Susan Bates, M.D., and Antonio "Tito" Fojo, M.D., Ph.D.: Thirty Years of Research, Discovery, Service, and Mentorship at the National Cancer InstituteSham Mailankody, Vinayak Prasad
JAMA Oncology|November 24, 2017
Overall Survival vs Disease-Specific Survival-ReplySham Mailankody, Vinay Prasad
JAMA Oncology|November 29, 2016
Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real WorldSham Mailankody, Vinay Prasad
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola Landgren
The New England Journal of Medicine|August 10, 2022
T-Cell Engagers - Modern Immune-Based Therapies for Multiple MyelomaSham Mailankody, Ola Landgren
Seminars in Oncology|February 6, 2022
"Off-the-shelf" immunotherapies for multiple myelomaTurab Mohammed, Sham Mailankody
JAMA|January 23, 2014
The accelerated approval of oncologic drugs: lessons from ponatinibVinay Prasad, Sham Mailankody
JAMA Oncology|September 11, 2015
Pricing and Value of Cancer Drugs--ReplySham Mailankody, Vinay Prasad
JAMA Internal Medicine|April 4, 2018
Assessing Pharmaceutical Research and Development Costs-ReplyVinay Prasad, Sham Mailankody
BMJ (Clinical Research Ed.)|September 22, 2020
Emerging immunotherapies in multiple myelomaUrvi A Shah, Sham Mailankody
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
The Oncologist|October 10, 2015
Susan Bates, M.D., and Antonio "Tito" Fojo, M.D., Ph.D.: Thirty Years of Research, Discovery, Service, and Mentorship at the National Cancer InstituteSham Mailankody, Vinayak Prasad
JAMA Oncology|November 24, 2017
Overall Survival vs Disease-Specific Survival-ReplySham Mailankody, Vinay Prasad
JAMA Oncology|November 29, 2016
Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real WorldSham Mailankody, Vinay Prasad
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola Landgren
The New England Journal of Medicine|August 10, 2022
T-Cell Engagers - Modern Immune-Based Therapies for Multiple MyelomaSham Mailankody, Ola Landgren
Seminars in Oncology|February 6, 2022
"Off-the-shelf" immunotherapies for multiple myelomaTurab Mohammed, Sham Mailankody
JAMA|January 23, 2014
The accelerated approval of oncologic drugs: lessons from ponatinibVinay Prasad, Sham Mailankody
JAMA Oncology|September 11, 2015
Pricing and Value of Cancer Drugs--ReplySham Mailankody, Vinay Prasad
JAMA Internal Medicine|April 4, 2018
Assessing Pharmaceutical Research and Development Costs-ReplyVinay Prasad, Sham Mailankody
BMJ (Clinical Research Ed.)|September 22, 2020
Emerging immunotherapies in multiple myelomaUrvi A Shah, Sham Mailankody
Pageof 18